EFG International AG Acquires Shares of 8,097 Stryker Corporation $SYK

EFG International AG acquired a new position in Stryker Corporation (NYSE:SYK) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 8,097 shares of the medical technology company’s stock, valued at approximately $2,550,000.

Several other large investors also recently made changes to their positions in the business. Sankala Group LLC acquired a new stake in Stryker in the 4th quarter valued at about $26,000. United Financial Planning Group LLC acquired a new position in shares of Stryker during the third quarter worth approximately $27,000. Godfrey Financial Associates Inc. bought a new stake in shares of Stryker during the fourth quarter valued at approximately $26,000. Atlas Capital Advisors Inc. bought a new position in Stryker in the 4th quarter worth approximately $27,000. Finally, Gables Capital Management Inc. acquired a new position in Stryker during the 2nd quarter worth $25,000. Institutional investors own 77.09% of the company’s stock.

Insider Activity

In other news, Director Ronda E. Stryker sold 300,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total value of $100,770,000.00. Following the completion of the transaction, the director owned 2,301,375 shares in the company, valued at $773,031,862.50. This represents a 11.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Debra King sold 826 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the sale, the insider directly owned 6,210 shares of the company’s stock, valued at $2,088,423. This represents a 11.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 351,267 shares of company stock worth $118,197,701 over the last quarter. 4.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

SYK has been the subject of several research reports. JPMorgan Chase & Co. lowered their target price on Stryker from $400.00 to $350.00 and set an “overweight” rating for the company in a research note on Friday, July 31st. Canaccord Genuity Group cut their price target on Stryker from $435.00 to $400.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Truist Financial lifted their price objective on Stryker from $330.00 to $340.00 and gave the stock a “hold” rating in a research report on Friday, July 31st. Weiss Ratings reissued a “hold (c)” rating on shares of Stryker in a report on Friday, July 31st. Finally, Royal Bank Of Canada cut their target price on shares of Stryker from $435.00 to $420.00 and set an “outperform” rating on the stock in a research report on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and an average target price of $386.28.

Stryker Price Performance

Shares of SYK stock opened at $330.08 on Thursday. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $396.86. The firm has a fifty day moving average of $328.37 and a 200-day moving average of $331.72. The firm has a market capitalization of $126.61 billion, a price-to-earnings ratio of 34.21, a price-to-earnings-growth ratio of 2.11 and a beta of 0.76.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, beating the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The business had revenue of $6.59 billion for the quarter, compared to analysts’ expectations of $6.58 billion. During the same quarter in the previous year, the business posted $3.13 EPS. Stryker’s revenue for the quarter was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, equities research analysts forecast that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.88 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s payout ratio is presently 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.